ResearcherFudan UniversityActive in the last 2 years

Qunyan Yao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3586-1911; OpenAlex author ID A5037678290. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Mesoporous Magnetic Graphene for Serum Metabolic Profiling in Non-Invasive Early Detection and Diagnosis of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1021/acsami.5c03176 ↗
Targeted delivery of CEBPA-saRNA for the treatment of pancreatic ductal adenocarcinoma by transferrin receptor aptamer decorated tetrahedral framework nucleic … First author DOI 10.1186/s12951-024-02665-4 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jia Qi · 1 shared paper, 2025 · strength 0.33
- Paper Mesoporous Magnetic Graphene for Serum Metabolic Profiling in Non-Invasive Early Detection and Diagnosis of Pancreatic … DOI 10.1021/acsami.5c03176 ↗
Guangqi Song · 1 shared paper, 2024 · strength 0.18
- Paper Targeted delivery of CEBPA-saRNA for the treatment of pancreatic ductal adenocarcinoma by transferrin receptor aptamer … DOI 10.1186/s12951-024-02665-4 ↗
Changfeng Zhu · 1 shared paper, 2024 · strength 0.18
- Paper Targeted delivery of CEBPA-saRNA for the treatment of pancreatic ductal adenocarcinoma by transferrin receptor aptamer … DOI 10.1186/s12951-024-02665-4 ↗
Li Wang · 1 shared paper, 2024 · strength 0.18
- Paper Targeted delivery of CEBPA-saRNA for the treatment of pancreatic ductal adenocarcinoma by transferrin receptor aptamer … DOI 10.1186/s12951-024-02665-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.